Ownership history in FCPM III SERVICES B.V. Β· 4 quarters on record
This page tracks every 13F SEC filing in which FCPM III SERVICES B.V. reported a position in ASTRIA THERAPEUTICS INC (ATXS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π FCPM III SERVICES B.V. underperformed the S&P 500 by β24.9% annually on this ATXS position. Timing score: 67% (2/3 decisions correct). Average cost basis: $7.86. Maximum drawdown during holding period: β40.3%.
β Significantly underperformed the S&P 500 by 24.9% ann.
3 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
2 of 3 add/trim decisions correct
Best entry: $5.34 (2025 Q1) Β· Worst: $8.94 (2024 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
3 adds Β· 0 trims. Bought during 1 of 1 down-price quarters. π Consistently bullish β fund kept accumulating this position.
π FCPM III SERVICES B.V. has been actively increasing its ATXS allocation β a bullish signal from insiders.
Currently 5.98% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size